Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Liminal BioSciences Inc. LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.


NDAQ:LMNL - Post by User

Post by stockbuphoonon Aug 01, 2021 12:33pm
81 Views
Post# 33638411

How much are you down, Newcamo?

How much are you down, Newcamo?You were buying at $20, $15, $10, $8, $6, $5, $4 and $3 if anyone could believe anything you say so you must be down a boatload. Still pumping those production jobs for a plant they sold and an FDA drug that they gave away to Kedrion. Voucher sale by end of year will bring money but they will have spent half of it on preclinical trials and bloated salaries. Is Pritchard worth the money  for all the amazing successes he has completed? 
<< Previous
Bullboard Posts
Next >>